Rosiglitazone diabetes drug molecule

Rosiglitazone diabetes drug molecule

A624/0537 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 79.5MB

Downloadable file size: 1,008.6KB

Price image Pricing

Please login to use the price calculator


Caption: Rosiglitazone diabetes drug, molecular model. Atoms are represented as spheres and are colour- coded: carbon (light blue), hydrogen (gold), oxygen (red), nitrogen (dark blue) and sulphur (yellow). Rosiglitazone, which is marketed under the name Avandia, belongs to a group of drugs known as thiazolidinediones that are used to treat type II diabetes. Rosiglitazone controls blood sugar levels by reducing the production and secretion of glucose by the liver and increasing the body's sensitivity to insulin, the hormone that regulates blood glucose levels. It requires that some insulin is produced by the pancreas and so cannot be used to treat type I diabetes.

Release details: Model release not required. Property release not required.

Keywords: anti-diabetic, antihyperglycaemic agent, antihyperglycemic agent, avandia, biochemical, biochemistry, blood glucose level, blood sugar level, chemical, chemistry, compound, compounds, diabetes, diabetic, drug, illustration, insulin sensitiser, medical, medicine, molecular, molecular model, molecule, molecules, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, rosiglitazone, single, space fill, space-fill, spacefill, sphere, spheres, structure, thiazolidinedione, type 2, type ii

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.